Researcher interests: Development of an original nano-delivery platform for improving the oral absorption of poorly absorbed drugs Taher Nassar, Suha Attili-Qadry, Ayala Rohald; Natasha Nayarkin and Simon Benita Based on combined technologies the aim of this novel nanoplatform is to release and enhance the intestinal absorption of drugs by encapsulating them in nanocapsules that are embedded in microparticles. This nanoplatform was shown to bypass the liver where part of the drug dose is degraded prior to reaching the blood circulation following oral administration since the drug-loaded nanocapsules permeated through the intestinal mucosa and reached the blood circulation via the lymphatic system.
FACULTY / SCHOOL: School of Medicine - IMRIC
Contact Business Development: Shani Bullock

Selected Publications

Simon Benita, Karra Nour
The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy (2012)| ingenta connect| Read more
Simon Benita, Oshrat Harush-Frenkel, Yoram Altschuler
Critical Reviews™ in Therapeutic Drug Carrier Systems (2008)| begell house - digital library| Read more
Simon Benita, Nir Debotton, Oshrat Harush-Frenkel, Yoram Altschuler
Targeting of nanoparticles to the clathrin-mediated endocytic pathway (2007)| ScienceDirect | Read more

Success Stories & related Product & PR

BioNanoSim Ltd.

BioNanoSim Ltd., (BNS) is an upscale company manufacturing nano-based delivery systems which are uniquely challenging for pharmaceutical development especially the production of polymeric biodegradable nanoparticles (NPs). Such NPs, once drug-...


Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
Contact ME: